Back to search
FDAFDA · Food and drugs·Recall number D-0769-2026

Kian Pee Wan Capsules, 30-count bottles

Published August 19, 2026 · Recall initiated: March 21, 2026

Summary

FDA records drug Class I recall D-0769-2026, published August 19, 2026 and initiated March 21, 2026. Recalling firm: Buy-Herbal; Status: Ongoing; Reported quantity: 71 bottles; Lot: All lots within expiry. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Buy-Herbal
Distributor
Product was sold to individual consumers via ebay third party seller.
Lot
All lots within expiry.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Kian Pee Wan Capsules, 30-count bottles recalled?

Yes. FDA published recall D-0769-2026 on August 19, 2026. Reported hazard: Marketed Without an Approved NDA/ANDA: Product contains undeclared drug ingredients dexamethasone and cyproheptadine.

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail